Wilson Sonsini Goodrich & Rosati, Skadden, Arps, Slate, Meagher & Flom, Gibson, Dunn & Crutcher and Cleary Gottlieb Steen & Hamilton are among six law firms advising on the $1.9 billion acquisition of OmniVision Technologies Inc by a consortium of Chinese investors.

The consortium, comprising Hua Capital Management Co, CITIC Capital Holdings and GoldStone Investment Co, will pay $29.75 per share for the company.

OmniVision Technologies Inc, whose customers include Apple Inc, is a maker of chips for smartphone and tablet cameras. The company has a design center and a testing facility in China and generates nearly 80 percent of its revenue from the country.

The Gibson, Dunn & Crutcher team led by Beijing partners Fang Xue, Joseph Barbeau and U.S.-based partners Sean Feller, Shaalu Mehra, Jeffrey Trinklein and Jose Fernandez acted as the lead counsel for the consortium. Zhong Lun Law Firm provided PRC legal advice.

Wilson Sonsini Goodrich & Rosati is acting for OmniVision in the transaction, while Grandall Law Firm is advising that party on PRC law.

A Skadden team led by Beijing based partners Peter Huang and Daniel Dusek, and Washington, D.C. partners Ivan Schlager and William Sweet, is advising GoldStone Investment on the deal. The team is also representing the buyer consortium with regards to Committee on Foreign Investment in the United States (CFIUS) matters.

The deal is expected to close in the third or fourth quarter of fiscal year 2016, and is subject to regulatory approval.

Related Articles

中伦、君合等牵头香港第二宗18C章上市项目(ZH/EN)

智能汽车芯片公司黑芝麻智能在香港联交所主板成功上市。发行人方面,中伦律师事务所担任中国律师,高伟绅律师事务所担任香港及美国律师,高盖茨律师事务所就美国出口管制法律提供意见;保荐人方面,君合律师事务所担任中国律师,美国威尔逊律师事务所担任香港及美国律师。

中概股接连迎来两宗重大交易,汉坤、凯易等扮演领衔角色(ZH/EN)

过去两周,来自中国湖北武汉的超跑电动车制造商路特斯,以及来自湖南长沙的互联网券商微牛,先后通过SPAC合并交易实现在美国纳斯达克上市。

竞天公诚、方达领衔药明合联香港IPO,创当年度纪录(ZH/EN)

by Mari Iwata |

近日,药明合联于香港交所主板成功上市,成为今年迄今为止在香港的第三大IPO,以及最大医疗健康和生物科技IPO项目。